VBS Pharmaceuticals announces publication of "Peptide-Directed Highly Selective Targeting of Pulmonary Arterial Hypertension" in the current issue of the American Journal of Pathology
VBS Pharmaceuticals, in collaboration with the Sanford-Burnham Medical Research Institute, and the University of South Alabama, announces the publication of a scientific article that describes a novel peptide that specifically targets and penetrates the vasculature of lungs affected by pulmonary arterial hypertension (PAH) in the current issue of the American Journal of Pathology.
The paper, "Peptide-Directed Highly Selective Targeting of Pulmonary Arterial Hypertension" (American Journal of Pathology 2011; 178(6): 2489-2495, by Takeo Urakami, Tero A.H. Järvinen, ...

